V68M (p.Val68Met) variant of CYP2A6 (Cytochrome P450 2A6)

V68M (p.Val68Met) in CYP2A6 (Cytochrome P450 2A6) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.48 / 1. The record also includes population frequency data and structural context.

V68M (p.Val68Met) variant details